Explore GEN family of websites, social media experiences, blogs and more.

Unleashing ideas.
Strengthening startups.

Back to search results
    Date submitted
  • 15-Feb-2016

AIME

Abstract

We predict disease outbreaks 3 months in advance using Artificial Intelligence, Epidemiology and Public Health expertise. Currently at 88.62% accuracy, our platform provides information to public health officers, saving lives and money.

Video

Original YouTube URL: Open

Introduction Video

Photos

Additional Questions

Who is your customer?

Initially, our target market consists of countries and non-governmental organizations most concerned by Dengue and Zika outbreaks. Each year, 50 to 100 million infections occur around the world and 2.5 billion people live in dengue endemic countries. Our focus is 40 countries in tropical climates primarily in Southeast Asia and South America. The current market size is $17.6 billion USD worldwide and growing, with an average annual expenditure of $440 million USD per country.

What problem does this idea/product solve or what market need does it serve?

In the next few decades, millions will die not to war or missiles, but microbes. While diseases evolve and we find new threats to humanity, our tools to tackle these do not. We are first tackling Dengue. Public Health officials do not know when or where the next dengue outbreak is going to strike, so they tend to take uninformed decisions that do not effectively curb a disease. Brazil alone spends 1.3billion USD managing dengue. Zika is now our second target, with its life threatening menace to babies and humanity.

What attributes will make this idea/product successful? Why do you believe that those features will create success?

Our platform provides its users with the exact geo location and date of the next dengue outbreak 3 months in advance quickly and intuitively. Along with the prediction we incorporate a fully customizable analytics platform to make sense of our users public health data providing time charts, historic mapping of diseases, rumor reports from social media, and much more. With this information public health governments are able to effectively tackle diseases and save money. Worldwide, there are 390 million dengue infections per year (WHO). In 2015, Brazil alone had more than one million cases. With our platform, we can reduce the cases, reducing them towards zero every year. We measure our success is by comparing the expected cases to the confirmed ones. Initially, we are working with Brazilian government in RioDeJaneiro and Sao Paulo, as well as in Malaysia. Our Business Model consists of yearly contracts based on the burden of disease.

Explain how you (your team) will execute to make this idea/product successful? What gives you (your team) an advantage over others already in the market or new to this market?

Our market penetration strategy is via smart partnerships, and success stories through the media. At Singularity University we got the verbal support from organizations such as Yunus Social Business, VivaRio and IBM. Alongside Singularity University, they would be considered smart partners. Success stories are the ones we have in Malaysia, where we successfully predicted dengue in two states. Our success stories generates letters of support from governments and media coverage. The letters help validate our work in countries in which we hope to work, and the media coverage is to reach countries internationally. (For example, according to our Dominican co-founder Rainier Mallol, people in Latin America are more wiling to cooperate with you If you've appeared in international media before.) Smart partners also include local NGOs that are close to a government, and that share the same social interest as us, but do not have the means to help as we do. They would be partners in introducing us to the different government entities. Such is the case with VivaRio, the NGO that is helping us reach Brazil.